171 related articles for article (PubMed ID: 11285030)
1. Cervical cancer in Canada: changing patterns in incidence and mortality.
Liu S; Semenciw R; Probert A; Mao Y
Int J Gynecol Cancer; 2001; 11(1):24-31. PubMed ID: 11285030
[TBL] [Abstract][Full Text] [Related]
2. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix--worldwide.
Mathew A; George PS
Asian Pac J Cancer Prev; 2009; 10(4):645-50. PubMed ID: 19827887
[TBL] [Abstract][Full Text] [Related]
3. Screening frequency and atypical cells and the prediction of cervical cancer risk.
Chen YY; You SL; Koong SL; Liu J; Chen CA; Chen CJ;
Obstet Gynecol; 2014 May; 123(5):1003-1011. PubMed ID: 24785853
[TBL] [Abstract][Full Text] [Related]
4. Invasive cervical cancer incidence and mortality among canadian women aged 15 to 29 and the impact of screening.
Popadiuk C; Stankiewicz A; Dickinson J; Pogany L; Miller AB; Onysko J
J Obstet Gynaecol Can; 2012 Dec; 34(12):1167-1176. PubMed ID: 23231799
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer in South Australia: trends in incidence, mortality and case survival.
Bonett A; Davy M; Roder D
Aust N Z J Obstet Gynaecol; 1989 Aug; 29(3 Pt 1):193-6. PubMed ID: 2604645
[TBL] [Abstract][Full Text] [Related]
6. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study.
Smith HO; Tiffany MF; Qualls CR; Key CR
Gynecol Oncol; 2000 Aug; 78(2):97-105. PubMed ID: 10926787
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
[TBL] [Abstract][Full Text] [Related]
8. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
[TBL] [Abstract][Full Text] [Related]
9. Changing incidence of invasive adenocarcinoma of the uterine cervix in East Anglia.
Stockton D; Cooper P; Lonsdale RN
J Med Screen; 1997; 4(1):40-3. PubMed ID: 9200062
[TBL] [Abstract][Full Text] [Related]
10. Trends in cancer of the cervix uteri in Sweden following cytological screening.
Bergström R; Sparén P; Adami HO
Br J Cancer; 1999 Sep; 81(1):159-66. PubMed ID: 10487628
[TBL] [Abstract][Full Text] [Related]
11. Incidence, survival and mortality in cervical cancer in Norway, 1956-1990.
Bjørge T; Thoresen SO; Skare GB
Eur J Cancer; 1993; 29A(16):2291-7. PubMed ID: 8110501
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of cervical cancer screening in Iceland, 1964-2002: a study on trends in incidence and mortality and the effect of risk factors.
Sigurdsson K; Sigvaldason H
Acta Obstet Gynecol Scand; 2006; 85(3):343-9. PubMed ID: 16553184
[TBL] [Abstract][Full Text] [Related]
13. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
14. Cervical carcinoma in women aged 34 and younger.
Carmichael JA; Clarke DH; Moher D; Ohlke ID; Karchmar EJ
Am J Obstet Gynecol; 1986 Feb; 154(2):264-9. PubMed ID: 3946514
[TBL] [Abstract][Full Text] [Related]
15. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
[TBL] [Abstract][Full Text] [Related]
16. Incidence, mortality and survival from invasive cervical cancer in Vaud, Switzerland, 1974-1991.
Levi F; La Vecchia C; Randimbison L; Te VC
Ann Oncol; 1994 Oct; 5(8):747-52. PubMed ID: 7826908
[TBL] [Abstract][Full Text] [Related]
17. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
[TBL] [Abstract][Full Text] [Related]
18. Reduced cervical cancer incidence and mortality in Canada: national data from 1932 to 2006.
Dickinson JA; Stankiewicz A; Popadiuk C; Pogany L; Onysko J; Miller AB
BMC Public Health; 2012 Nov; 12():992. PubMed ID: 23158654
[TBL] [Abstract][Full Text] [Related]
19. Cancer of the uterine cervix in Norway by histologic type, 1970-84.
Eide TJ
J Natl Cancer Inst; 1987 Aug; 79(2):199-205. PubMed ID: 3474452
[TBL] [Abstract][Full Text] [Related]
20. Trends in cervical and breast cancer in Iceland. A statistical evaluation of trends in incidence and mortality for the period 1955-1989, their relation to screening and prediction to the year 2000.
Sigurdsson K; Adalsteinsson S; Ragnarsson J
Int J Cancer; 1991 Jun; 48(4):523-8. PubMed ID: 2045199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
